🔗 Share this article

A shadow economy for unapproved slimming medications is being driven by social media fitness personalities and sellers on communication apps, according to new investigations.

Investigational Drug Acquiring Traction Online

The experimental drug, which is still in research studies, is being advertised by social media influencers for its alleged fat-burning effects. Followers are urged to contact these accounts directly for supplier links, while also obtaining discount codes.

Active Trade on Social Networks

Additionally, a robust market exists on messaging services, where communities with thousands of members share “before and after” images, injection guides and assertions of next-day UK delivery. Vendors promote the drug there before redirecting buyers to other platforms for transactions.

Understanding Retatrutide

Retatrutide is an experimental injection created by US drugmaker Eli Lilly. The treatment targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could assist patients reduce up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being promoted online as the next Ozempic.

Healthcare Experts Express Concerns

Nevertheless, doctors and chemists have warned that the distribution of what remains an unlicensed drug in the United Kingdom is worrisome and could lead to users administering products of unknown origin.

Some experts said the demand for the experimental drug could be connected to the increasing price of approved weight loss products such as Mounjaro.

Regulatory Status and Implementation

Marketing the unapproved drug on social media or Telegram is illegal in the UK, as it is an unapproved medication that must not be promoted or supplied for human use under the British medical regulations.

Several content creators attempt to circumvent the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but promotion and supply can still breach medicines, advertising, and customer laws, potentially leading to penalties, legal action or imprisonment.

Service Response and Content Elimination

According to TikTok, the service has taken down problematic material and banned associated keywords and query recommendations. The company stated it was dedicated to maintaining the service safe and investing in enhancing enforcement strategies.

Online Trading Activities

Investigations also found communities with up to nine thousand members marketing retatrutide using Telegram's integrated search feature, which operates like a public directory. Typing “retatrutide” immediately brings up channels with thousands of users, filled with photos of slimming results, positive testimonials and step-by-step guides for mixing or injecting at residence.

Within minutes of joining one group, a vendor posted WhatsApp details, where most transactions take place. The vendor sent an guidebook and promised delivery within two days. When questioned whether the product was authentic, one vendor said: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. Not one asked about body mass, medical conditions or past usage.

Product Information and Costs

Within these groups, posts display dark colored packages with postal service labels, claiming to include fresh supplies. One communication read: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, prepared at home with purified liquid, or ready-to-use pens typically sold at 160 pounds for 20 milligrams. When questioned how long a pen should be used, sellers give conflicting responses varying between a several days to “depends on your body”.

Service Moderation and Security Measures

A spokesperson for Telegram said it regularly moderated dangerous material on its platform including content that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“Individuals are administering materials they can’t verify. Even if the research behind this drug is sound, these digital products may not contain what they claim,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U.

A medical professional of Asda Online Doctor connected the increase in interest to recent price rises for authorized weight-loss drugs such as Mounjaro. “With prices increasing, patients are turning to online platforms. But counterfeit treatments are extremely dangerous. You cannot know what’s contained or whether the conditions they were made in was sterile,” she said.

Her team has previously seen patients harmed by self-injection from unverified suppliers. “We understand the frustration, but purchasing from messaging apps or WhatsApp is gambling with your health,” said the doctor. “These materials could be impure or incorrectly dosed.”

Manufacturer Statement

A representative from Eli Lilly stated retatrutide was in phase 3 research studies and had not been reviewed or authorized by any government authority globally. “Consequently at this time no one can sell [it] for human use,” they explained, adding that any product “falsely representing itself as a Lilly experimental product not yet approved … may subject users to possibly serious medical dangers”.